Cáncer Renal segunda línea - page 26

Champiat S, et al. Ann Oncol 2016
Immune-Related Adverse Events (irAE)
1...,16,17,18,19,20,21,22,23,24,25 27,28,29,30,31,32,33,34,35
Powered by FlippingBook